Treace Medical Concepts (TMCI) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free TMCI Stock Alerts $5.88 +0.13 (+2.26%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 31 at 5:52 AM | americanbankingnews.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Director Purchases $253,500.00 in StockMay 30 at 6:10 PM | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCIMay 30 at 9:53 AM | marketbeat.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Sees Large Growth in Short InterestTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) was the recipient of a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 4,550,000 shares, a growth of 49.7% from the April 30th total of 3,040,000 shares. Based on an average daily trading volume, of 994,100 shares, the days-to-cover ratio is presently 4.6 days. Approximately 10.4% of the shares of the company are short sold.May 30 at 7:56 AM | insidertrades.comInsider Buying: Treace Medical Concepts, Inc. (NASDAQ:TMCI) Director Buys 50,000 Shares of StockMay 29 at 7:34 PM | marketbeat.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Director Buys $253,500.00 in StockTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) Director James T. Treace acquired 50,000 shares of the firm's stock in a transaction dated Tuesday, May 28th. The shares were purchased at an average price of $5.07 per share, with a total value of $253,500.00. Following the completion of the transaction, the director now owns 1,089,441 shares of the company's stock, valued at $5,523,465.87. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website.May 28, 2024 | globenewswire.comTreace to Present at Truist Securities MedTech ConferenceMay 25, 2024 | americanbankingnews.comRichard W. Mott Buys 12,100 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) StockMay 24, 2024 | insidertrades.comInsider Buying: Treace Medical Concepts, Inc. (NASDAQ:TMCI) Director Purchases 12,100 Shares of StockMay 23, 2024 | marketbeat.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Director Richard W. Mott Buys 12,100 SharesTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) Director Richard W. Mott bought 12,100 shares of Treace Medical Concepts stock in a transaction that occurred on Wednesday, May 22nd. The shares were acquired at an average price of $4.99 per share, with a total value of $60,379.00. Following the acquisition, the director now directly owns 1,054,944 shares of the company's stock, valued at approximately $5,264,170.56. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.May 22, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCIMay 21, 2024 | insidertrades.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) CEO Purchases $556,000.00 in StockMay 20, 2024 | marketbeat.comInsider Buying: Treace Medical Concepts, Inc. (NASDAQ:TMCI) CEO Acquires 100,000 Shares of StockTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) CEO John T. Treace acquired 100,000 shares of the business's stock in a transaction on Friday, May 17th. The shares were purchased at an average price of $5.56 per share, for a total transaction of $556,000.00. Following the purchase, the chief executive officer now directly owns 6,343,095 shares of the company's stock, valued at $35,267,608.20. The transaction was disclosed in a filing with the SEC, which is available through this link.May 19, 2024 | 247wallst.comCEOs and Other Insiders Are Buying Shares of These 7 StocksMay 17, 2024 | msn.comUBS Downgrades Treace Medical Concepts (TMCI)May 17, 2024 | businesswire.comKirby McInerney LLP Announces Investigation of Shareholder Claims Against Treace Medical Concepts, Inc. (TMCI)May 16, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCIMay 16, 2024 | markets.businessinsider.comUnveiling 6 Analyst Insights On Treace Medical ConceptsMay 16, 2024 | marketbeat.comTreace Medical Concepts (NASDAQ:TMCI) Cut to "Neutral" at UBS GroupUBS Group cut Treace Medical Concepts from a "buy" rating to a "neutral" rating and decreased their target price for the stock from $16.00 to $6.50 in a research note on Thursday.May 15, 2024 | finance.yahoo.comDirector Jane Kiernan Acquires 19,356 Shares of Treace Medical Concepts Inc (TMCI)May 14, 2024 | finance.yahoo.comDirector Richard Mott Acquires 120,000 Shares of Treace Medical Concepts Inc (TMCI)May 14, 2024 | finance.yahoo.comDirector Deepti Jain Acquires 25,000 Shares of Treace Medical Concepts Inc (TMCI)May 14, 2024 | insidertrades.comInsider Buying: Treace Medical Concepts, Inc. (NASDAQ:TMCI) Director Purchases 25,000 Shares of StockMay 13, 2024 | marketbeat.comDeepti Jain Buys 25,000 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) StockTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) Director Deepti Jain bought 25,000 shares of the business's stock in a transaction dated Friday, May 10th. The stock was acquired at an average price of $4.50 per share, for a total transaction of $112,500.00. Following the purchase, the director now directly owns 31,235 shares in the company, valued at $140,557.50. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.May 13, 2024 | finance.yahoo.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Q1 2024 Earnings Call TranscriptMay 10, 2024 | finance.yahoo.comEarnings Update: Treace Medical Concepts, Inc. (NASDAQ:TMCI) Just Reported And Analysts Are Trimming Their ForecastsMay 9, 2024 | msn.comMorgan Stanley Downgrades Treace Medical Concepts (TMCI)May 9, 2024 | msn.comBTIG Downgrades Treace Medical Concepts (TMCI)May 9, 2024 | marketbeat.comTimesSquare Capital Management LLC Raises Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI)TimesSquare Capital Management LLC boosted its position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 22.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,749,120 shares of the coMay 8, 2024 | msn.comOrthopedic Devices Maker Treace Medical Concepts' Gloomy Forecast Cast Concerns Over Long-Term ViabilityMay 8, 2024 | msn.comTreace Medical crashes as guidance cut prompts J.P. Morgan downgradeMay 8, 2024 | marketbeat.comUBS Group Lowers Treace Medical Concepts (NASDAQ:TMCI) Price Target to $16.00UBS Group reduced their price target on Treace Medical Concepts from $17.00 to $16.00 and set a "buy" rating for the company in a report on Wednesday.May 8, 2024 | marketbeat.comTreace Medical Concepts (NASDAQ:TMCI) Releases Earnings Results, Meets EstimatesTreace Medical Concepts (NASDAQ:TMCI - Get Free Report) released its earnings results on Tuesday. The company reported ($0.30) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.30). Treace Medical Concepts had a negative net margin of 26.47% and a negative return on equity of 33.96%. The firm had revenue of $51.11 million during the quarter, compared to analyst estimates of $49.07 million. During the same quarter last year, the business earned ($0.23) EPS. The business's revenue was up 21.1% on a year-over-year basis.May 8, 2024 | investorplace.comWhy Is Treace Medical Concepts (TMCI) Stock Down 59% Today?May 8, 2024 | marketbeat.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Recommendation of "Moderate Buy" by BrokeragesShares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the six analysts that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and five have issued a buyMay 8, 2024 | finance.yahoo.comTreace Medical Concepts Inc (TMCI) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...May 7, 2024 | finance.yahoo.comTreace Medical Concepts Inc (TMCI) Q1 2024 Earnings: Revenue Surpasses Estimates, Net Loss WidensMay 7, 2024 | finance.yahoo.comTreace Medical Concepts Reports First Quarter 2024 Financial ResultsApril 27, 2024 | nasdaq.comTreace Medical Concepts is Now Oversold (TMCI)April 24, 2024 | globenewswire.comTreace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA TourApril 17, 2024 | finance.yahoo.comTreace to Present at Bank of America Health Care ConferenceApril 16, 2024 | globenewswire.comTreace Announces First Annual National Bunion DayApril 15, 2024 | investorplace.com7 Stable Stocks for 50% Returns by Early 2025April 12, 2024 | marketbeat.comTreace Medical Concepts (NASDAQ:TMCI) Shares Down 5.2% Treace Medical Concepts (NASDAQ:TMCI) Stock Price Down 5.2%April 9, 2024 | globenewswire.comTreace to Report First Quarter 2024 Financial ResultsApril 9, 2024 | marketbeat.comVanguard Group Inc. Has $54.93 Million Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI)Vanguard Group Inc. boosted its position in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 3.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,189,582 shares of the company's stock afterApril 1, 2024 | marketbeat.comTreace Medical Concepts (NASDAQ:TMCI) Shares Down 4% Treace Medical Concepts (NASDAQ:TMCI) Trading Down 4%March 27, 2024 | marketbeat.comTreace Medical Concepts (NASDAQ:TMCI) Trading Up 7.6%Treace Medical Concepts (NASDAQ:TMCI) Trading 7.6% HigherMarch 25, 2024 | globenewswire.comTreace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient MilestoneMarch 18, 2024 | marketbeat.comWalleye Capital LLC Grows Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI)Walleye Capital LLC raised its holdings in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 171.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 139,839 shares of the company's stock aftMarch 12, 2024 | marketbeat.comQube Research & Technologies Ltd Buys 95,194 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI)Qube Research & Technologies Ltd raised its stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 146.2% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 160,284 shares of th Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s arrest is phase one (Ad)In this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now. TMCI Media Mentions By Week TMCI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TMCI News Sentiment▼1.090.78▲Average Medical News Sentiment TMCI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TMCI Articles This Week▼92▲TMCI Articles Average Week Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Organogenesis News Sintx Technologies News MiMedx Group News AtriCure News Artivion News Perspective Therapeutics News Silk Road Medical News OrthoPediatrics News Atrion News Embecta News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TMCI) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
